MYO1F — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL4699731	1.00	2/20
SCHEMBL16111548	1.00	2/20
SCHEMBL29358745	1.00	2/20
SCHEMBL29380618	1.00	2/20
SCHEMBL29931136	1.00	2/20
SCHEMBL4697866	0.89	2/20
SCHEMBL24532075	0.89	2/20
SCHEMBL4697696	0.86	2/20
SCHEMBL23092285	0.86	2/20
SCHEMBL29688472	0.86	2/20
SCHEMBL22024695	0.86	2/20
SCHEMBL16136600	0.84	2/20
SCHEMBL24532058	0.83	2/20
SCHEMBL4699947	0.83	2/20
SCHEMBL22025026	0.82	2/20
SCHEMBL22119546	0.82	2/20
SCHEMBL24532062	0.82	2/20
SCHEMBL18804561	0.81	2/20
SCHEMBL22024561	0.81	2/20
SCHEMBL22025030	0.81	2/20

Clinical trials — most relevant to MYO1F by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
The Effect of Neuromuscular Electrical Stimulation (NMES)	PHASE2	COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability	PHASE1	COMPLETED
Characteristics of Nondystrophic Myotonias	nan	COMPLETED
Transcutaneous Functional Magnetic Muscle Stimulation in Critically Ill	nan	UNKNOWN
Chronic Muscle Disuse in the Elderly	nan	COMPLETED
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure	nan	RECRUITING
Genetic Testing in Primary Congenital Glaucoma Patients	nan	UNKNOWN
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China	nan	ENROLLING_BY_INVITATION
Natural History Study for Patients With Nemaline Myopathy in Belgium	nan	NOT_YET_RECRUITING
Molecular and Genetic Studies of Congenital Myopathies	nan	RECRUITING
PITA-HF: Feasibility, Safety, and Tolerability	nan	COMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer	nan	UNKNOWN
3D-Microscopic Muscle Architecture in Cerebral Palsy	nan	RECRUITING
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease	nan	COMPLETED
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome	nan	COMPLETED
Muscle Tissue Bank for Muscular Dystrophy	nan	COMPLETED
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease	nan	COMPLETED
Contractile Cross Sectional Areas and Muscle Strength in Patients With Congenital Myopathies	nan	COMPLETED
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy	nan	RECRUITING
WiTNNess - TNNT1 Myopathy Natural History Study	nan	RECRUITING
Registry of Unexplained Cardiac Arrest	nan	COMPLETED
The Muscle in Cerebral Palsy; Sarcomere Length in Vivo and Microscopic Characterization of Biopsies.	nan	RECRUITING
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms	nan	COMPLETED
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development	nan	COMPLETED
Idiopathic Dilated Cardiomyopathy	nan	COMPLETED
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia	nan	COMPLETED
The Prevalence of RYR1-related Disease	nan	NOT_YET_RECRUITING
Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia	nan	COMPLETED
Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure?	nan	RECRUITING
Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a MYO1F binder may also engage these)

Protein	Name	Similarity
P70248	—	0.999	P70248 →
E9Q634	—	0.995	E9Q634 →
Q9WTI7	—	0.993	Q9WTI7 →
Q12965	—	0.993	Q12965 →
Q27966	—	0.992	Q27966 →
Q63356	—	0.992	Q63356 →
Q6CVE9	—	0.990	Q6CVE9 →
A4RE77	—	0.989	A4RE77 →
Q92002	—	0.988	Q92002 →
P0CP00	—	0.988	P0CP00 →
A5DKH0	—	0.987	A5DKH0 →
O00159	—	0.987	O00159 →
Q6C7C0	—	0.987	Q6C7C0 →
A8PWF6	—	0.987	A8PWF6 →
Q99323	—	0.986	Q99323 →
Q758Q9	—	0.986	Q758Q9 →
P0CP01	—	0.986	P0CP01 →
P10568	—	0.986	P10568 →
A7TDZ8	—	0.985	A7TDZ8 →
A6SED8	—	0.985	A6SED8 →
Q63355	—	0.985	Q63355 →
O88329	—	0.985	O88329 →
A2AQP0	—	0.984	A2AQP0 →
Q9UBC5	—	0.984	Q9UBC5 →
P02565	—	0.984	P02565 →
Q5ZLA6	—	0.984	Q5ZLA6 →
Q6FMJ3	—	0.983	Q6FMJ3 →
Q29P71	—	0.983	Q29P71 →
A7EK16	—	0.983	A7EK16 →
P13542	—	0.983	P13542 →